Acerca de
Nuestra Labor
Datos y herramientas
Eventos
Noticias
Congress-On-Demand-EN

Ya está disponible el acceso gratuito al contenido A pedido del Congreso 2022

El Congreso Mundial 2022 de la FMH fue un éxito rotundo, con miles de asistentes de 145 países, quienes participaron tanto en persona, en Montreal, como de manera virtual. La FMH ahora tiene el gusto de ofrecerle acceso gratuito al contenido A pedido del evento.

También disponible en: English Français 日本語

Si no pudo acompañarnos en mayo, ahora es su oportunidad de tener acceso a más de veinte sesiones informativas presentadas por expertos ponentes. El acceso gratuito incluye las siguientes sesiones:

Hay interpretación en francés y en español disponible para todas las sesiones mencionadas a continuación.

  • Plenary: Arosenius Lecture: Towards Novel Treatment Options in von Willebrand Disease
  • Plenary: Moving on from COVID-19 as a global community
  • Humanitarian Aid, A pass to sustainable care
  • von Willebrand Disease and von Willebrand Factor
  • Changing Treatment, Changes Diagnosis, Part 1
  • Late – Breaking #1 Clinical Research
  • Perspectives on Curing Hemophilia
  • Plenary: Gene Therapy – are we ready now?
  • Plenary: Making Unspeakable, the personal journey behind creating a series about the Canadian tainted blood crisis
  • Championing Change: Improving Access Globally
  • Gene Therapy Practical Aspects of Implementations
  • Memorial Art: Remembering the Past, Changing the Future
  • Late-breaking #2 Clinical Research
  • VP Medical Address
  • Plenary: Therapeutic and Technological Advancements in Hemophilia Care: Quantum Leaps Forward
  • Improving National Standards of care with WFH Treatment Guidelines
  • Non-Factor Therapy
  • Pain in Women and Girls with Bleeding Disorders
  • Late Breaking #3 Clinical Research
  • Data & Demographics Workshop: Improving Patient Outcomes Through Data: Part 1: WFH Data Collection programs
  • Data & Demographics Workshop: Improving Patient outcomes through data: Part 2: Improvements/New approaches in using data
  • Data & Demographics Workshop: Improving Patient outcomes through data: Part 3: Data as a tool for advocacy – An interactive exercise

¡No espere más! Su acceso a las sesiones gratuitas termina el 11 de julio de 2022.

Además de lo anterior, hay otras 35 sesiones de especialidad disponibles (únicamente en inglés) a través de la versión pagada del acceso A pedido, las cuales abarcan las siguientes:

  • Women and Bleeding Disorders Workshop: Case Study Discussion for WGBDs
  • MSK Management with and without Technology
  • Changing treatment, changes diagnosis – Patient Panel
  • Health Issues in women and girls affected by hemophilia
  • Big picture initiatives in bleeding disorders
  • Hemophilia gene therapy: Update on new country initiatives
  • Diagnosis of rare bleeding disorders
  • Reducing Anxiety and Stress for people impacted by a bleeding disorder
  • ¡Y más!

Para ver la lista completa de todo el contenido disponible, y para inscribirse, utilice el enlace que aparece abajo. Todas las sesiones estarán disponibles hasta el 11 de julio de 2022.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.